Bafna Pharmaceuticals, a Chennai-based pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non–Betalactum, received approval from UK Medicines and Healthcare products Regulatory Agency (MHRA) to manufacture Amlodipine 5mg and Amlodipine 10mg.
It is the 13th formulation approval (site variation) received from UK MHRA for a product by Bafna Pharmaceuticals Ltd. Recently Bafna Pharma received approval from Ghana Food and Drug Administration (FDA) to market a hypertension drug Atenolol 50 mg and Atenolol 100 mg tablets.